203 related articles for article (PubMed ID: 23152495)
1. Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.
Barbolina MV; Liu Y; Gurler H; Kim M; Kajdacsy-Balla AA; Rooper L; Shepard J; Weiss M; Shea LD; Penzes P; Ravosa MJ; Stack MS
J Biol Chem; 2013 Jan; 288(1):141-51. PubMed ID: 23152495
[TBL] [Abstract][Full Text] [Related]
2. Wnt/beta-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover.
Yasuhara R; Yuasa T; Williams JA; Byers SW; Shah S; Pacifici M; Iwamoto M; Enomoto-Iwamoto M
J Biol Chem; 2010 Jan; 285(1):317-27. PubMed ID: 19858186
[TBL] [Abstract][Full Text] [Related]
3. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
4. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
5. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
[TBL] [Abstract][Full Text] [Related]
6. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.
Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K
Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518
[TBL] [Abstract][Full Text] [Related]
7. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
Barbolina MV; Adley BP; Ariztia EV; Liu Y; Stack MS
J Biol Chem; 2007 Feb; 282(7):4924-4931. PubMed ID: 17158885
[TBL] [Abstract][Full Text] [Related]
8. TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions.
Gaud G; Iochmann S; Guillon-Munos A; Brillet B; Petiot S; Seigneuret F; Touzé A; Heuzé-Vourc'h N; Courty Y; Lerondel S; Gruel Y; Reverdiau P
J Cell Mol Med; 2011 Feb; 15(2):196-208. PubMed ID: 20015200
[TBL] [Abstract][Full Text] [Related]
9. DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma.
Hirata H; Hinoda Y; Majid S; Chen Y; Zaman MS; Ueno K; Nakajima K; Tabatabai ZL; Ishii N; Dahiya R
Cancer; 2011 Apr; 117(8):1649-60. PubMed ID: 21472712
[TBL] [Abstract][Full Text] [Related]
10. Frizzled gene expression and negative regulation of canonical WNT-β-catenin signaling in mouse F9 teratocarcinoma cells.
Golenia G; Gatie MI; Kelly GM
Biochem Cell Biol; 2017 Apr; 95(2):251-262. PubMed ID: 28177772
[TBL] [Abstract][Full Text] [Related]
11. N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway.
Sengupta PK; Bouchie MP; Kukuruzinska MA
J Biol Chem; 2010 Oct; 285(41):31164-73. PubMed ID: 20693288
[TBL] [Abstract][Full Text] [Related]
12. Dickkopf-1 mediated tumor suppression in human breast carcinoma cells.
Mikheev AM; Mikheeva SA; Maxwell JP; Rivo JV; Rostomily R; Swisshelm K; Zarbl H
Breast Cancer Res Treat; 2008 Nov; 112(2):263-73. PubMed ID: 18157634
[TBL] [Abstract][Full Text] [Related]
13. A novel functional screen in human cells identifies MOCA as a negative regulator of Wnt signaling.
Caspi E; Rosin-Arbesfeld R
Mol Biol Cell; 2008 Nov; 19(11):4660-74. PubMed ID: 18716063
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model.
Saupe F; Schwenzer A; Jia Y; Gasser I; Spenlé C; Langlois B; Kammerer M; Lefebvre O; Hlushchuk R; Rupp T; Marko M; van der Heyden M; Cremel G; Arnold C; Klein A; Simon-Assmann P; Djonov V; Neuville-Méchine A; Esposito I; Slotta-Huspenina J; Janssen KP; de Wever O; Christofori G; Hussenet T; Orend G
Cell Rep; 2013 Oct; 5(2):482-92. PubMed ID: 24139798
[TBL] [Abstract][Full Text] [Related]
15. Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of β-catenin/E-cadherin signaling.
Cho SW; Lee EJ; Kim H; Kim SH; Ahn HY; Kim YA; Yi KH; Park DJ; Shin CS; Ahn SH; Cho BY; Park YJ
Mol Cell Endocrinol; 2013 Feb; 366(1):90-8. PubMed ID: 23261982
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Wnt/β-catenin signaling by dexamethasone promotes adipocyte differentiation in mesenchymal progenitor cells, ROB-C26.
Naito M; Omoteyama K; Mikami Y; Takahashi T; Takagi M
Histochem Cell Biol; 2012 Dec; 138(6):833-45. PubMed ID: 22886144
[TBL] [Abstract][Full Text] [Related]
17. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
20. Chondroprotective effects of palmatine on osteoarthritis in vivo and in vitro: A possible mechanism of inhibiting the Wnt/β-catenin and Hedgehog signaling pathways.
Zhou X; Lin X; Xiong Y; Jiang L; Li W; Li J; Wu L
Int Immunopharmacol; 2016 May; 34():129-138. PubMed ID: 26945831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
